NU SKIN ENTERPRISES, INC. financials

  1. Home
  2. Financials
  3. NUS
NUS CIK 0001021561

Source: EDGAR filings · Built 2026-06-02T03:41:57Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 43.77M 67.27M 56.95M 47.09M 71.10M 314.61M
EBITDA 118.02M -81.78M 119.19M 183.35M 310.31M 331.56M
Working Capital 283.96M 241.99M 373.00M 400.63M 343.26M 360.34M
Net Debt 70.01M 292.21M 351.46M 254.68M 164.60M 97.99M
Gross Margin 69.45% 68.23% 68.93% 71.65% 74.95% 74.51%
Operating Margin 4.43% -8.75% 2.45% 4.98% 8.68% 9.98%
Net Margin 10.79% -8.46% 0.44% 4.71% 5.46% 7.41%
Return on Equity (ROE) 19.90% -22.50% 1.05% 11.68% 16.13% 21.40%
Return on Assets (ROA) 11.40% -9.98% 0.48% 5.75% 7.72% 9.78%
Current Ratio 2.08× 1.82× 2.13× 2.12× 1.65× 1.66×
Debt-to-Equity 0.38× 0.74× 0.74× 0.58× 0.55× 0.56×
Effective Tax Rate 18.35% 16.26% 67.66% -17.77% 36.65% 25.32%
Cash Conversion Ratio 0.50× -0.76× 13.80× 1.03× 0.96× 1.98×
Accruals Ratio 0.06× -0.18× -0.06× -0.00× 0.00× -0.10×
SBC % of Revenue 1.62% 0.86% 0.79% 0.56% 0.86% 0.93%
CapEx Coverage 2.20× 2.51× 1.92× 1.77× 2.01× 5.88×
Free Cash Flow Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.01

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 3.03× — 114.24× 20.37× 17.74× 15.05×
P/FCF — 4921.43× — — — 9105.00×
FCF Yield 0.01% 0.02% 0.01% 0.00% 0.00% 0.01%
EV / EBITDA 7.98× — 17.71× 22.22× 15.35× 15.22×
P/S 0.59× 0.36× 0.89× 1.72× 1.71× 1.92×
P/B 1.08× 0.96× 2.14× 4.26× 5.04× 5.53×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.49B 1.73B 1.97B 2.23B 2.70B 2.58B
Cost of Goods and Services Sold 453.76M 550.23M 611.85M 630.91M 675.22M 658.03M
Gross Profit 1.03B 1.18B 1.36B 1.59B 2.02B 1.92B
Research and Development Expense 10.80M 13.00M 22.60M 23.30M 27.20M 23.30M
Operating Expenses 965.63M 1.33B 1.31B 1.48B 1.79B 1.67B
Operating Income (Loss) 65.76M -151.59M 48.27M 110.85M 233.99M 257.56M
Income Tax Expense (Benefit) 35.99M -28.46M 17.98M -15.81M 85.19M 64.88M
Net Income (Loss) Attributable to Parent 160.20M -146.59M 8.60M 104.78M 147.27M 191.35M
Earnings Per Share, Basic $3.25 $-2.95 $0.17 $2.10 $2.93 $3.66
Weighted Average Number of Shares Outstanding, Basic 49.29B 49.66B 49.71B 50.00B 50.19B 52.30B
Earnings Per Share, Diluted $3.18 $-2.95 $0.17 $2.07 $2.86 $3.63
Weighted Average Number of Shares Outstanding, Diluted 50.30B 49.66B 49.86B 50.52B 51.43B 52.77B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 238.63M 186.88M 256.06M 264.73M 339.59M 402.68M
Assets, Current 547.70M 538.60M 701.87M 759.87M 872.95M 903.20M
Assets 1.41B 1.47B 1.81B 1.82B 1.91B 1.96B
Liabilities, Current 263.73M 296.61M 328.87M 359.24M 529.69M 542.86M
Long-term Debt, Excluding Current Maturities 204.19M 363.61M 478.04M 377.47M 268.78M 305.39M
Liabilities 600.07M 817.46M 986.66M 923.67M 993.71M 1.06B
Stockholders' Equity Attributable to Parent 805.24M 651.46M 821.97M 897.30M 912.77M 894.27M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 80.29M 111.74M 118.64M 108.06M 141.58M 379.14M
Payments to Acquire Property, Plant, and Equipment 34.28M 41.58M 58.49M 59.06M 68.61M 63.82M
Net Cash Provided by (Used in) Investing Activities 170.66M -37.96M -134.50M -67.08M -88.73M -79.43M
Payments for Repurchase of Common Stock 20.04M 0 13.01M 70.05M 80.42M 144.33M
Net Cash Provided by (Used in) Financing Activities -202.40M -133.18M 10.73M -99.50M -104.70M -245.17M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NUS CIK 0001021561), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MANH

MANHATTAN ASSOCIATES, INC.

TMHC

TAYLOR MORRISON HOME CORP

COSO

COASTALSOUTH BANCSHARES, INC.